HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 26,150
-950 (-3.51%)
At close: Oct 29, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 188.52 billion as of October 28, 2026. It is the 22,544th most valuable company in the world and the 834th biggest in South Korea. Its market cap has decreased by 7.56% in one year.
Market Cap
188.52B
Enterprise Value
200.21B
Revenue
16.14B
Global Rank
Country Rank
#834 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 188.52B, an increase of 65.11%. That is a compound annual growth rate of 28.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 188.52B | -42.44% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 260.50B |
| GC WellBeing | 195.18B |
| DAE HWA Pharmaceutical | 177.22B |
| Vivozon Pharmaceutical | 174.48B |
| NOVAREX | 156.54B |
| CellBion | 154.48B |
| Kyung Dong Pharmaceutical | 143.72B |
| HYUNDAI BIOLAND | 124.65B |